Latest Freeze of Gait Companies Update:
Acorda Therapeutics: In July 2023, Acorda Therapeutics received FDA approval for INBRIJA (levodopa/carbidopa/inhibitor) oral film, a fast-acting levodopa treatment for "off" episodes in Parkinson's disease, including FoG.
Medtronic: In March 2023, Medtronic announced the launch of its DBS Therapy for Parkinson's disease, a deep brain stimulation system that can help manage symptoms like FoG.
Gondola Medical Technologies: In December 2023, Gondola Medical Technologies secured EUR 27 million in funding to expand its development and commercialization of its GaitGuard system, a wearable device that uses electrical stimulation to improve gait in patients with Parkinson's disease and FoG.
Ustep: In January 2024, Ustep received FDA clearance for its Walk with Path system, a wearable device that uses biofeedback and augmented reality to help patients with Parkinson's disease improve gait and reduce FoG episodes.
List of Freeze of Gait Key companies in the market
- Teva Pharmaceuticals (Israel)
- Sun Pharmaceutical Industries Ltd (India)
- Viatris Inc (US)
- Gondola Medical Technologies SA (Switzerland)
- Gyenno Technologies Co., Ltd. (China)
- Beats Medical Limited (Ireland)
- Agilitas (Australia)
- Walk with Path (Vesterbro)
- MedEXO Robotics (Hong Kong)
- Ustep (US)